Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    9 days ago
    Change Detected
    Summary
    No content additions or deletions were detected between the two screenshots; the page content and structure remain the same, with only minor rendering differences.
    Difference
    0.3%
    Check dated 2025-10-29T04:47:13.000Z thumbnail image
  2. Check
    31 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T16:09:18.000Z thumbnail image
  3. Check
    39 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T10:12:48.000Z thumbnail image
  4. Check
    53 days ago
    Change Detected
    Summary
    Location naming was updated to 'Tatarstan, Respublika' and 'Kazan, Tatarstan, Respublika, Russia, 420029' with a full country/postal context. The revision tag changed from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-15T01:09:34.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T21:28:45.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous locations across various countries and detailed drug information for multiple medications, while also removing outdated location references and some drug categories.
    Difference
    17%
    Check dated 2025-08-31T19:52:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.